Scientists at The University of Texas at El Paso are developing a less invasive portable device that would use blood samples to detect colorectal cancers. Their device is described in a new study published in the journal ACS Measurement Science Au.

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods. Addressing this critical need, City University of Hong Kong (CityUHK) is leading a groundbreaking research project aimed at developing an innovative technology platform for early detection of cancer and personalised treatment. The project aims specifically to enhance the detection of circulating tumor cells (CTCs), paving the way for significant advancements in cancer diagnosis and care. This is one of the first batch of projects that has secured funding by the RAISe+ Scheme.

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy drug, according to a study in Cancer Cell. In addition, an analysis of the tumors after one month of immunotherapy identified which type of immune cells were activated to fight the cancer. These insights could help individualize treatment benefits.

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer.

Genalive, a joint venture of BGI Genomics, has secured a three-year centralized procurement project for outsourced testing services in Saudi Arabia's public hospitals, with a contract value of 950 million RMB.